Neurotone AI Launches Tinnitus Pro
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Neurotone AI has launched Tinnitus Pro, a personalized digital tinnitus therapy platform that blends sound therapy, CBT-based tools, and clinician-connected monitoring.
Regeneron’s DB-OTO gene therapy for genetic hearing loss is one of nine drugs to receive expedited review under FDA's new CNPV program.
Dr Jane Madell reflects on the evolution of pediatric audiology technology and testing methods while emphasizing the enduring importance of early diagnosis, behavioral testing, and fitting children with appropriate devices.
For clinics, adopting these strategies to address financial considerations not only builds trust but also helps patients achieve a better quality of life.
The therapy targets mutations in the CLIC5 gene, which affect hair cell stability and lead to progressive hearing and balance impairments.
The Audiology Practice Standards Organization is inviting public review and comment on its new draft standard to ensure profession-supported best practices in tinnitus evaluation.
A large-scale study found no evidence that musical training enhances early auditory brain processing, challenging long-held assumptions.
FAU researchers developed a novel AI-powered platform that uses real-time video analysis and deep learning to diagnose nystagmus remotely.
Beltone has relaunched its nationwide Hear2End Hunger Food Drive, combining efforts to combat food insecurity with free hearing screenings to raise awareness of the link between nutrition and hearing health.